Gilead is developing inhaled remdesivir
Embed this video
Share
Description
Gilead Sciences is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled. Fred Katayama reports.
General Info
UploadedJun 03, 2020
watch more videos